ProPhase Labs, Inc. (PRPH)
OTCMKTS · Delayed Price · Currency is USD
0.027118
-0.001982 (-6.81%)
At close: Aug 20, 2026

ProPhase Labs Financials Overview

Millions USD. Fiscal year is Jan - Dec.

Revenue & Profits

Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingJun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Revenue
3.854.356.7734.98122.6579.04
Revenue Growth
-31.16%-35.82%-80.65%-71.48%55.17%444.59%
Gross Profit
0.651.38-0.1515.5670.6541.99
Operating Income
-15.56-18.05-38.63-21.2223.69.8
Net Income
-22.46-14.74-53.36-16.7818.466.27
Earnings Per Share
-1.71-1.74-26.68-9.7510.243.95
EPS Growth
----158.92%-

Cash & Debt

Fiscal YearCurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingJun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Cash & Investments
0.020.090.684.7417.4417.26
Total Debt
9.128.6224.5718.466.9614.9
Net Cash (Debt)
-9.1-8.53-23.9-13.7210.482.36
Net Cash Growth
----343.56%-
Net Cash Per Share
-0.69-1.00-11.95-7.975.621.28

Cash Flow & CapEx

Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingJun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Operating Cash Flow
-5.54-8.34-17.54-11.8928.55-13.62
Capital Expenditures
---0.91-2.08-3.92-4.23
Free Cash Flow
-5.54-8.34-18.44-13.9724.63-17.85
Free Cash Flow Growth
------

Margins

Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingJun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Gross Margin
16.77%31.85%-2.22%44.47%57.61%53.12%
Operating Margin
-404.50%-415.35%-570.59%-60.66%19.24%12.40%
Pretax Margin
-568.13%-538.25%-625.26%-64.02%18.68%6.71%
Profit Margin
-583.91%-339.31%-788.24%-47.97%15.05%7.94%
FCF Margin
-144.06%-192.04%-272.44%-39.94%20.08%-22.58%

Valuation

Fiscal YearCurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingAug '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
PE Ratio
----8.4917.70
Forward PE
-40.5640.5640.5615.6926.51
P/FCF Ratio
----6.36-
PS Ratio
0.100.482.672.331.281.41